Panobacumab (Serotype IATS O12) - Research Grade Biosimilar
Product Specifications
Background
Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa) .
Immunogen
Homo sapiens / Serotype IATS O12 [Pseudomonas aeruginosa, Gram negative bacteria]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Infectious Disease
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgM-kappa
Other Product Names
Aerumab 11, KBPA101
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400270-100 1x 100 µL
Fibronectin (HFN7.1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470204-500 1x 500 µL
Complement C4d (C4D204), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680836-500 1x 500 µL
Cytokeratin 18 (KRT18/836), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401491-100 1x 100 µL
PAX8 (Renal Cell Marker) (PAX8/1491), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471370-100 1x 100 µL
Adiponectin (Marker of Obesity) (ADPN/1370), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details